-
Functional changes
-
Cardiac changes
Diastolic dysfunction (decreased left ventricular diastolic compliance, impaired relaxation, reduced early diastolic filling, increased late diastolic filling)
Increased left ventricular wall thickness
Impaired left ventricular ejection and heart rate reserve capacity
Altered heart rhythm (decreased heart rate variability, increased cardiac arrhythmias)
Deficits in sympathetic modulation of heart rate and left ventricular contractility
Prolongation of cardiac action potential
-
Vascular changes
Endothelial dysfunction
-
Histological and cellular changes
Decrease in total number of cardiomyocytes (increased apoptosis and necrosis)
Increased myocyte size (myocyte hypertrophy)
Increased collagen content in the connective tissue of the heart
Increased cardiac fibrosis
Decreased No. of pacemaker cells
Prolongation of cardiac action potential
Reduced regenerative capacity and decline in number of cardiac stem cells
Aortic wall thickness and arterial intimal thickening
-
Molecular changes
-
Blunted cardiac β-adrenergic response
-
Impaired calcium handling
-
Impaired mitochondrial function
-
Alterations in cardiac metabolism
Decrease in myocardial fat utilization and oxidation
TCA compromised, increased glycolysis
Renin-angiotensin-aldosterone system activation
Increased cardiac angiotensin II concentrations
Reduced insulin/IGF signaling
|